pharmaceutical companies on efforts to provide global access to medicines?

1,020 views

Published on

A presentation by Wim Leereveld at TBLI CONFERENCE EUROPE 2008.

0 Comments
3 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,020
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
34
Comments
0
Likes
3
Embeds 0
No embeds

No notes for slide
  • pharmaceutical companies on efforts to provide global access to medicines?

    1. 1. TBLI Conference November 2008
    2. 2. What defines the Access to Medicine Index a yearly ranking of pharmaceutical companies on efforts to provide global access to medicines? TBLI Conference November 2008
    3. 3. How to engage the pharmaceutical industry through transparency? Scope, Results and Benefits of the Access to Medicine Index TBLI Conference November 2008
    4. 4. TBLI Conference November 2008
    5. 5. 80% of the population 20% of the medicine 20% of the population 80% of the medicine TBLI Conference November 2008
    6. 6. How come ? TBLI Conference November 2008
    7. 7. Pharmaceutical Industry responsible? TBLI Conference November 2008
    8. 8. <ul><li>Should </li></ul><ul><li>they be involved? </li></ul>Pharmaceutical Industry TBLI Conference November 2008
    9. 9. <ul><li>Access to Medicine in developing countries: </li></ul><ul><li>is part of their CSR policy </li></ul><ul><li>means market presence and future growth </li></ul><ul><li>is important for their image </li></ul>Pharmaceutical Industry TBLI Conference November 2008
    10. 10. <ul><li>Can we help them to take a better role? </li></ul><ul><li>Yes, we can! </li></ul>Pharmaceutical Industry TBLI Conference November 2008
    11. 11. If you want to change something, you should first know where you are <ul><li>ATM Index measures where individual Pharmaceutical companies are on the path of improving access to medicine in developing countries </li></ul>TBLI Conference November 2008
    12. 12. How? TBLI Conference November 2008
    13. 13. TBLI Conference November 2008
    14. 14. The Challenge TBLI Conference November 2008
    15. 15. Access to Medicine Index Engaging industry through transparency <ul><li>Defines benchmarks on the role industry could play in improving ATM </li></ul><ul><li>Measures and ranks top 20 pharma companies </li></ul>TBLI Conference November 2008
    16. 16. TBLI Conference November 2008 November 15 th 2007: “ Innovest Selected as the Best ESG Consultancy/Research House” Innovest Strategic Value Advisors was selected as the Best ESG Consultancy/ Research House by TBLI and Investment & Pensions Europe at the first ever ESG Leaders Awards for the investors, investment management and research community.   Innovest STRATEGIC VALUE ADVISORS
    17. 17. SUPPORT FROM DAY ONE TBLI Conference November 2008
    18. 18. TBLI Conference November 2008
    19. 19. The road towards consensus TBLI Conference November 2008
    20. 20. Index Model TBLI Conference November 2008
    21. 22. TBLI Conference November 2008
    22. 23. Access to Medicine Index 2008 TBLI Conference November 2008 <ul><li>Industry leaders - Perform well on most Index Criteria </li></ul><ul><li>significant Access to Medicine strategy </li></ul><ul><li>strong access to medicine management systems </li></ul><ul><li>relatively transparent in public policy and advocacy </li></ul><ul><li>equitable pricing and licensing agreements to increase greater access to affordable drugs investing in R&D programs </li></ul><ul><li>Middle ranked companies – Less sophisticated strategies </li></ul><ul><ul><li>Do have specific access to medicine programs in place </li></ul></ul><ul><ul><li>fail to consistently address all key issues in the access to medicine debate. </li></ul></ul><ul><li>Lower ranked companies – Do not consider AtM as a key issue </li></ul><ul><ul><li>No formal access to medicine policy </li></ul></ul><ul><ul><li>disclose little information on their efforts to improve access to medicine. </li></ul></ul><ul><ul><li>no clear commitment to respond to access to medicine challenges in the future. </li></ul></ul>
    23. 24. Does this work ? <ul><li>Access to Medicine Index as a tool for improvement: </li></ul><ul><li>Best practices are defined and recognized </li></ul><ul><li>Companies want to perform well in rankings </li></ul><ul><li>Rankings are tools for investors </li></ul>TBLI Conference November 2008
    24. 25. Interest investors <ul><li>Indicator for good management -> Long term profit </li></ul><ul><li>Ready for business in developing countries </li></ul><ul><li>Use image in negotiations </li></ul>TBLI Conference November 2008
    25. 26. $ 1.5 trillion Investor Support TBLI Conference November 2008
    26. 27. Transparency benefits <ul><li>World attention for the ATM problem via press coverage </li></ul><ul><li>Investors get opportunity to play their role </li></ul><ul><li>Analysing best practises, no excuses for inabilities </li></ul><ul><li>Companies increase performance according to their ranking </li></ul><ul><li>Companies are rewarded for good behaviour </li></ul><ul><li>Use of the data by a variety of stakeholders </li></ul>TBLI Conference November 2008
    27. 28. Support
    28. 29. www.atmindex.org TBLI Conference November 2008
    29. 30. TBLI Conference November 2008

    ×